KLOW blend

Summary

KLOW adds the anti-inflammatory tripeptide KPV to the three components of GLOW. It is a supplier-defined product with no published research on the combination.

Components

• Copper-binding tripeptide GHK-Cu GHK-Cu is a naturally occurring copper-binding tripeptide found in human plasma, saliva and urine. Early human data
• Synthetic pentadecapeptide BPC-157 BPC-157 is a synthetic 15-amino-acid peptide studied mainly for tendon, ligament, muscle and gut healing in rodents. Animal studies
• Thymosin beta-4 peptide TB-500 TB-500 is the trade name for synthetic thymosin beta-4 or its active fragment. Early human data
• Anti-inflammatory tripeptide KPV KPV is the C-terminal tripeptide of alpha-MSH and carries much of that hormone’s anti-inflammatory activity without its pigment effects. Animal studies

How it works

KPV was studied in intestinal and skin inflammation models, and suppliers add it on the theory that reducing inflammation complements the repair-oriented components.

Research use cases

Areas where KLOW blend has been studied. Inclusion here does not mean it works for that purpose.

• Combines the research areas of its components; see each component profile

What the research found

Safety and open questions

Combining compounds can change how each behaves, and fixed ratios mean you cannot adjust one without the other. Component purity and identity are harder to verify in a blend, because a single certificate of analysis must confirm several peptides.

Regulatory status

Not approved. A supplier-defined combination; no regulator has evaluated it.

Status was accurate when this page was last reviewed on October 26, 2026. Regulations change; check with the relevant authority before relying on it.